Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: Up-and down-regulation of CD13/aminopeptidase N

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 663-667

  Imamura, Nobutaka ^a   Kimura, Akiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CD13 aminopeptidase N; Cell growth inhibition; Flow cytometric analysis; HL 60 cell; Ubenimex(Bestatin)

Indexed keywords

BESTATIN; CD11 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; MICROSOMAL AMINOPEPTIDASE; ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; LEUCINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE INHIBITOR; TUMOR PROTEIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; DIMETHYL SULFOXIDE; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUCINE; NEOPLASM PROTEINS; PROTEASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

EID: 0034101686     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058523     Document Type: Article

References (15)

1. Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T (1976). Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiot., 29, 97-99.
2. Abe F, Shibuya K, Uchida M, Takahashi K, Horinishi H, Matsuda A, Ishizuka M, Takeuchi T, Umezawa H (1984). Effect of bestatin on syngeneic tumor in mice. Gann, 75, 89-94.
3. Abe F, Kuramochi H, Takahashi K, Ishizuka M, Takeuchi T(1988). Biological activity of the main metabolites of ubenimex in humans. J. Antibiot., 41, 1862-1867.
4. Talmadge JE, Lenz BF, Pennington R, Long C, Phillips H, Schneider M, Tribble H (1986). Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res., 46, 4505-4510.
5. Look AT, Ashmun RA, Shapiro LH, Peiper SC (1989). Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.J. Clin. Invest., 83, 1299-1307.
6. Ashmun RA, Look AT (1990). Metalloprotease activity of CD13/Aminopeplidase N on the surface of human myeloid cells. Blood, 75, 462-469.
7. Imamura N, Tanaka R, Kajihara H, Kuramoto A (1988). Analysis of peroxidase negative acute unclassifiable leukemias by monoclonal antibodies. I.Acute myelogenous leukemia and acute myelomonocytic leukemia. Eur. J. Haematol., 41, 420-428.
8. Imamura N, Kajihara H, Kuramoto A (1988). Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies. II.Acute megakaryoblastic and acute promegakaryocytic leukemias. Leuk. Res., 12, 274-289.
9. Imamura N, Kuramoto A (1989). Analysis of peroxidase negative acute leukemias by monoclonal antibodies. III.Acute lymphoblastic leukemia. J. Clin. Lab. Anal., 3, 88-94.
10. Imamura N, Kusunoki Y, Kawa-Ha K, Yumura K, Hara J, Oda K, Abe K, Dohy H, Inada T, Kajihara H, Kuramoto A (1990). Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br.J. Haematol., 75, 49-59.
11. Imamura N, Mtasiwa DM, Inada T, Kuramoto A (1990). Different expression of CD36 antigen molecule on the surface of megakaryocyte lineage leukemias and megakaryocyte leukemia cell lines MEG-01 and HEL. Leukemia, 4, 525-528.
12. Mitani K, Hangaishi A, Imamura N, Miyagawa K, Ogawa S, Kanda Y, Yazaki Y, Hirai H (1997). No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. Leukemia, 11, 863-865.
13. Nishizawa R, Saino T, Takita T, Suda H, Aoyagi T, Umezawa H (1977). Synthesis and structure-activity relationships of bestatin analogues, inhibitors of aminopeptidase B. J. Med. Chem., 20, 510-515.
14. Kobayashi T, Kageyama S, Deguchi H, Katayama N, Wada H, Nishikawa M, Tanaka I, Suzuki H, Nakase K, Tamaki S, Sekine T, Yamaguchi T, Oka K, Uemura Y, Murashima S, Kawakami K, Deguchi K, Shirakawa S, Shiku H (1996). Clinical effects of ubenimex on acute myeloid leukemia. Biotherapy, 10, 873-878.
15. Imamura N, Kuramoto A (1991). Bone marrow transplantation. Present status and future prospects. J. Hiroshima Med. Ass., 44, 1548-1553.